Librea, Vevencio .
HRN: 23-23-37 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/25/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/25/2023
07/02/2023
IV
500mg
Q8hrs
T/C Partial Small Bowel Obstruction
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes